Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease

被引：0
|
作者：
Rawaha Ahmad
Andrey Postnov
Guy Bormans
Jan Versijpt
Mathieu Vandenbulcke
Koen Van Laere
机构：
[1] KU Leuven and University Hospitals Leuven,Department of Imaging & Pathology, Nuclear Medicine and Molecular Imaging
[2] University Hospital Leuven,Division of Nuclear Medicine
[3] National Research Nuclear University MEPhI,Laboratory for Radiopharmacy
[4] KU Leuven,Department of Neurology
[5] University Hospital Brussels,Old Age Psychiatry, Department of Psychiatry
[6] KU Leuven and University Hospitals Leuven,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2016年 / 43卷
关键词：
Cannabinoid type 2 receptor; CB; R; Neuroinflammation; PET imaging; Alzheimer’s disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2219 / 2227
页数：8
相关论文
共 50 条
  • [1] Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease
    Ahmad, Rawaha
    Postnov, Andrey
    Bormans, Guy
    Versijpt, Jan
    Vandenbulcke, Mathieu
    Van Laere, Koen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (12) : 2219 - 2227
  • [2] In vivo type 1 cannabinoid receptor availability in Alzheimer's disease
    Ahmad, Rawaha
    Goffin, Karolien
    Van den Stock, Jan
    De Winter, Francois-Laurent
    Cleeren, Evy
    Bormans, Guy
    Tournoy, Jos
    Persoons, Philippe
    Van Laere, Koen
    Vandenbulcke, Mathieu
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 (02) : 242 - 250
  • [3] Research progress on the cannabinoid type-2 receptor and Parkinson's disease
    Yu, Xiaoqi
    Jia, Yi
    Dong, Yuan
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 15
  • [4] Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer's disease mouse model
    Schmoele, Anne-Caroline
    Lundt, Ramona
    Ternes, Svenja
    Albayram, Oender
    Ulas, Thomas
    Schultze, Joachim L.
    Bano, Daniele
    Nicotera, Pierluigi
    Alferink, Judith
    Zimmer, Andreas
    NEUROBIOLOGY OF AGING, 2015, 36 (02) : 710 - 719
  • [5] Type-1 Cannabinoid Receptor Activity During Alzheimer's Disease Progression
    Manuel, Ivan
    Gonzalez de San Roman, Estibaliz
    Teresa Giralt, M.
    Ferrer, Isidro
    Rodriguez-Puertas, Rafael
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (03) : 761 - 766
  • [6] Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer's disease
    Kecheliev, Vasil
    Spinelli, Francesco
    Herde, Adrienne
    Haider, Ahmed
    Mu, Linjing
    Klohs, Jan
    Ametamey, Simon M.
    Ni, Ruiqing
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [7] CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease
    Aso, Ester
    Ferrer, Isidro
    FRONTIERS IN NEUROSCIENCE, 2016, 10
  • [8] Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology
    Schmoele, Anne-Caroline
    Lundt, Ramona
    Toporowski, Gregor
    Hansen, Jan N.
    Beins, Eva
    Halle, Annett
    Zimmer, Andreas
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 64 (02) : 379 - 392
  • [9] In vivo PET imaging of neuroinflammation in Alzheimer's disease
    Lagarde, Julien
    Sarazin, Marie
    Bottlaender, Michel
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (05) : 847 - 867
  • [10] In vivo PET imaging of neuroinflammation in Alzheimer’s disease
    Julien Lagarde
    Marie Sarazin
    Michel Bottlaender
    Journal of Neural Transmission, 2018, 125 : 847 - 867
12345